Thomas Russell Dietze

M.D. | Cornea and External Diseases Specialist | 44+ years Exp


Medicare Enrolled
 5402 S Staples St, Suite 100, Corpus Christi
    Texas, 78411-4656

 361-992-9400    361-992-8295   Maps & Directions
Thomas Russell Dietze is a Corpus Christi, Texas based Cornea and External Diseases Specialist with 44 years of experience in Cornea and External Diseases Specialist. He completed his graduation from University Of Nebraska College Of Medicine in 1982. He is also affiliated with hospitals like South Texas Surgical Hospital. He accepts the Medicare-approved amount. Patients will not be billed for any more than the Medicare deductible and coinsurance. Active license number of Thomas Russell Dietze is H1574 for Ophthalmology in Texas.
Thomas Russell Dietze specializes in diseases of the cornea, sclera, eyelids, conjunctiva, and anterior segment of the eye. This subspecialty includes the medical and surgical management of corneal and external eye diseases, including corneal transplantation, refractive surgery, and the treatment of ocular surface disorders.
Complete Profile:
Thomas Russell Dietze speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Specialization: Cornea and External Diseases Specialist
Credentials: M.D.
Experience: 44+ years
Medical School Attended:University Of Nebraska College Of Medicine
Graduation Year:1982
Gender:Male
Accepts Medicare Assignment:Yes
Practice Address:5402 S Staples St, Suite 100, Corpus Christi,
Texas, 78411-4656
Phone:361-992-9400
Fax:361-992-8295
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 3173585601
Enrollment ID: I20100803000039
NPI Number: 1417938713
NPI Enumeration Date: 14 Nov, 2005
NPI Last Update On: 28 Feb, 2019
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Thomas Russell Dietze are as mentioned below.
License NumberSpecializationStateStatus
H1574Ophthalmology TexasPrimary
H1574Cornea and External Diseases Specialist TexasSecondary
Hospital Affiliation:
Doctors can be affiliated to many hospitals whom they worked with in the past or are presently working with. One surgeon can be affiliated to four to five hospitals at a time.
Hospital Name (CCN) State Hospital Type
South Texas Surgical Hospital (670061)Corpus christi, TXAcute Care Hospital
Group Practice:
Group practices are run by a group of physicians who share their premises and other resources. Following list states all the group name with which Thomas Russell Dietze has association with along with the number of members in that group.
Organization Name (Group PAC ID) Members
South Texas Eye Consultants, Pllc (9335203611)3
Other Medical Identifiers:
Other legacy medical identifiers associated with Thomas Russell Dietze such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
IdentifierTypeStateIssuer
129833303MedicaidTexas
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 5402 S Staples St, Suite 100
Corpus Christi, Texas
Zip: 78411-4656
Phone Number: 361-992-9400
Fax Number: 361-992-8295
Patients can reach Thomas Russell Dietze at 5402 S Staples St, Suite 100, Corpus Christi, Texas or can call to book an appointment on 361-992-9400.
Comments/ Reviews:
Patients can read all the reviews posted for Thomas Russell Dietze below. You may also share your own experience like the quality of treatment, behavior, and overall care provided by Thomas Russell Dietze. It will help others make informed decisions.
** Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 July, 2026.